GW-0742 Capsules

€ 59,95

GW-0742 capsules contain a formulated presentation of a PPARβ/δ research ligand and thiazole derivative offered by Raw Lab Chems with seller-specified ≥99% purity. The material is intended exclusively for controlled in-vitro, chemical, structural, and analytical research.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-13113 Category:
Description

GW-0742 Capsules

Product Overview

GW-0742 capsules provide a formulated presentation of GW-0742, a synthetic research compound described in the supplied information as a PPARβ/δ agonist and thiazole derivative. The compound is associated with experimental investigation of PPARδ-mediated transcription, ligand-receptor interactions, cellular metabolic pathways, and comparative PPAR chemistry.

Raw Lab Chems presents this material exclusively for controlled in-vitro, chemical, and analytical research. The supplied specification states ≥99% purity for the underlying research compound. This value is treated as a seller-provided specification rather than independently verified analytical data.

The supplied information discusses research involving fatty-acid oxidation, mitochondrial function, inflammatory-response pathways, glucose utilization, and energy-homeostasis signaling. These subjects describe areas of experimental investigation rather than therapeutic, metabolic-enhancement, weight-management, endurance, athletic, or other personal-use benefits.

The capsule format represents a formulated research material and should be analytically distinguished from isolated GW-0742 powder or other reference materials.

Chemical Identity & Classification

The supplied systematic chemical name for GW-0742 is [4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid.

The supplied molecular formula is C21H17F4NO3S2. The source classifies the material as a PPARβ/δ agonist / thiazole derivative.

The systematic name identifies structurally relevant features including fluorophenyl, trifluoromethyl, thiazole, thioether, methylphenoxy, and acetic-acid functionality. These characteristics can be relevant to structural characterization and analytical differentiation from related experimental PPAR ligands.

The source additionally describes GW-0742 as a structural analogue of GW-501516 and attributes a fluorine substitution as an area of comparative research involving binding affinity and metabolic stability. This is retained as research context rather than interpreted as a performance characteristic.

No CAS number or molecular weight was supplied in this capsule-specific source, so neither is introduced as a supplied product specification.

Researchers can consult PubChem for public chemical-reference information while confirming that any selected database record corresponds to the exact material under investigation.

Chemical & Physical Characteristics

The supplied product is described as encapsulated powder intended for laboratory measurement. No verified capsule color, shell composition, dimensions, fill appearance, excipient profile, particle-size distribution, or other formulation-specific physical characteristics were supplied.

The molecular formula C21H17F4NO3S2 describes the underlying GW-0742 compound rather than the complete capsule formulation. Any capsule-shell material or excipients would represent additional components and should be considered separately during formulation-specific analytical work.

No quantitative solubility, melting point, density, hygroscopicity, or other detailed physicochemical measurements were provided in this source. Such characteristics are therefore not inferred from related PPAR ligands or from information supplied for other GW-0742 formats.

The supplied storage guidance specifies room-temperature conditions between 15°C and 25°C in a dry environment protected from light. No product-specific stability study, degradation profile, or validated shelf-life dataset accompanied the supplied information.

Purity & Analytical Verification

The supplied specification for GW-0742 capsules states ≥99% purity for the underlying research compound.

The source additionally states that HPLC analysis is used to assess chemical purity and formulation concentration. Mass spectrometry and proton NMR are described as methods used to verify structural characteristics, including the trifluoromethyl and fluorophenyl components.

No batch-specific chromatogram, mass spectrum, NMR spectrum, Certificate of Analysis, or independent analytical report accompanied the supplied information. Accordingly, the ≥99% specification and associated testing statements are presented as seller-supplied information rather than independently verified analytical results.

HPLC, LC-MS, GC-MS, NMR, and related instrumental techniques can be relevant to GW-0742 characterization when appropriately validated for the intended analytical objective. Depending on methodology, these techniques may support investigation of identity, purity, structural characteristics, impurities, and differentiation from related ligands.

For formulated research materials, chemical purity and formulation uniformity are distinct analytical characteristics. A purity specification for the underlying compound does not independently establish uniform distribution throughout every formulated unit.

Quality Control & Batch Integrity

Reliable laboratory investigation requires documentation connecting experimental observations to the precise research material examined. Useful records can include chemical identity, formulation type, supplier, lot or batch identifier, receipt date, storage history, analytical observations, and chain-of-custody information where appropriate.

The supplied source describes HPLC analysis, mass-spectrometric and proton-NMR characterization, formulation concentration assessment, manufacturing controls, batch consistency, and Certificate of Analysis availability.

No underlying chromatograms, spectra, Certificates of Analysis, manufacturing records, formulation-validation studies, or batch-specific analytical reports were supplied. These statements therefore remain source-provided quality information rather than independently established characteristics.

Researchers requiring verified identity, purity, formulation uniformity, impurity profiling, or batch consistency should rely on documentation applicable to the exact research sample or perform suitable independent analytical characterization.

No additional third-party certification, manufacturing-standard, or lot-to-lot reproducibility guarantee is made without supporting evidence.

Safety, Handling & Laboratory Precautions

GW-0742 should be handled exclusively by appropriately trained personnel in a controlled laboratory environment. Suitable personal protective equipment, ventilation, containment, access controls, and waste-management procedures should be established through institutional risk assessment and applicable safety documentation.

The compound’s experimental relationship with PPAR signaling should be considered when laboratories establish suitable controls. Molecular or cellular activity does not establish safety or suitability for human or veterinary exposure.

Researchers should consult an applicable Safety Data Sheet for the exact compound and formulation when developing procedures concerning accidental exposure, spills, contamination, environmental release, waste collection, and disposal.

Research material should remain secured against unauthorized access and separated from food, beverages, children, pets, and non-research environments. Handling procedures should also minimize unintended contamination of analytical equipment, work surfaces, samples, and laboratory waste streams.

Packaging, Labeling & Storage

The supplied information describes high-barrier, moisture-resistant, and UV-protective packaging intended to maintain chemical stability during transportation. No packaging specification, validation study, or supporting technical documentation was supplied to independently confirm these characteristics.

Storage guidance specifies dry conditions between 15°C and 25°C with protection from light. These conditions are retained as source-provided guidance rather than represented as independently validated Raw Lab Chems stability specifications.

Researchers should follow documentation applicable to the specific batch, relevant SDS guidance, and institutional chemical-storage requirements.

Because the material is supplied as a capsule formulation, laboratory records should distinguish the complete formulation from isolated GW-0742 reference material. Labels should preserve the compound identity together with lot or batch information where available. Storage history should also be documented where environmental variables could influence analytical observations or formulation integrity.

Intended Research Use & Market Positioning

GW-0742 is relevant to laboratory investigation of PPARδ signaling, ligand-receptor interactions, receptor-mediated transcription, comparative PPAR chemistry, structural analysis, and analytical method development.

The supplied source additionally identifies fatty-acid oxidation, mitochondrial biology, glucose utilization, inflammatory-response pathways, cardiac and skeletal-muscle cell models, and energy-homeostasis signaling as experimental contexts. These references describe research subjects rather than established biological or commercial benefits.

The source also identifies LC-MS and GC-MS calibration and validation for metabolic-modulator screening as analytical contexts. Such work can support controlled analytical identification and comparative reference studies when suitable validated methods are used.

Researchers comparing related catalog materials can separately examine Raw Lab Chems SR-9009 Powder (Stenabolic) and SR-9009 Stenabolic Capsules. These represent a different research compound and product formats and should not be treated as chemically or analytically interchangeable with GW-0742.

The Raw Lab Chems GW-0742 Capsules research listing provides the catalog reference for the formulation described here.

No medical, therapeutic, diagnostic, veterinary, metabolic-enhancement, weight-management, bodybuilding, athletic-performance, or consumptive application is represented by this description.

Ordering, Availability & Fulfillment

Institutional procurement of GW-0742 should begin with confirmation of the required formulation, chemical identity, analytical documentation, institutional authorization, and jurisdiction-specific requirements applicable to the proposed research.

The supplied source refers to standard laboratory counts but does not establish current package configurations or inventory. Availability should therefore not be inferred from this description.

The source additionally describes high-barrier packaging and professional, discreet worldwide shipping. These statements are not presented as verified Raw Lab Chems fulfillment guarantees because supporting packaging and logistics documentation was not supplied.

No claims are made concerning current inventory, package configurations, dispatch schedules, delivery times, shipping destinations, courier services, tracking, payment methods, customs processing, or geographic availability.

Researchers and institutions remain responsible for determining whether acquisition, possession, import, export, transfer, storage, and investigation of GW-0742 are permitted and appropriately authorized under applicable requirements.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

GW-0742 is presented as an experimental laboratory research compound. Regulatory treatment may differ according to jurisdiction, intended research activity, institutional policy, and applicable medicines, sporting, chemical-control, forensic, or research frameworks.

Researchers and institutions are responsible for determining and complying with requirements governing acquisition, possession, licensing, import, export, transfer, storage, security, research, environmental handling, and disposal.

A research-use designation does not establish universal legality, medical approval, suitability as a dietary supplement, or exemption from anti-doping, medicines, chemical-control, institutional, or other applicable requirements.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “GW-0742 Capsules”
Shipping & Delivery